secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0000950170-25-006024
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 2.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Carmell closes acquisition of Elevai Skincare; issues ~1.15M shares, $2.5M revenue portfolio
--------------------------------------------------------------------------------

- Purchase consideration: ~1.1M shares of Carmell common at $0.8488/sh, plus 117,814 holdback shares for 12-month indemnification.
- Earnout: 5% of annual net sales from existing products for 5 years; $500k milestone if hair/scalp products reach $500k revenue within 24 months.
- Acquired assets include product portfolio with FY2024 revenue ~$2.5M, inventory ~$1.0M, and accounts receivable ~$0.03M.
- Post-closing Carmell common shares outstanding ~30.1M; Chairman expects synergies, expanded portfolio, and improved cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000095017025006024/0000950170-25-006024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000095017025006024/ctcx-20250116.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-006024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer